Protagonist Therapeutics, Inc. (PTGX)

82.76 -0.33 (-0.40%) USD  |  NASDAQ  |  Feb 20, 16:00
82.77 +0.01 (+0.01%) After-Hours: 20:00
More

Protagonist Therapeutics Long Term Deferred Tax Assets (Quarterly)

Long Term Deferred Tax Assets (Quarterly) Chart

View Long Term Deferred Tax Assets (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Assets (Quarterly) Benchmarks

View Long Term Deferred Tax Assets (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Glaukos Corp. Upgrade
Krystal Biotech, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. --